Prediction of nonresponsiveness to medium-dose intravenous immunoglobulin (1 g/kg) treatment: an effective and safe schedule of acute treatment for Kawasaki disease

PURPOSE: Medium-dose (1 g/kg) intravenous immunoglobulin (IVIG) is effective in the majority of patients with Kawasaki disease (KD) but some patients who do not respond to medium-dose IVIG are at high risk for the development of coronary artery lesions (CALs). The purpose of this study was to identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Kyung Pil, Kim, Beom Joon, Lee, Kyu Jin, Oh, Jin Hee, Han, Ji Whan, Lee, Kyung Yil, Lee, Soon Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pediatric Society 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865641/
https://www.ncbi.nlm.nih.gov/pubmed/27186228
http://dx.doi.org/10.3345/kjp.2016.59.4.178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865641/
https://www.ncbi.nlm.nih.gov/pubmed/27186228
http://dx.doi.org/10.3345/kjp.2016.59.4.178

Ejemplares similares